Default company panoramic image


Patient-specific optimized 3D cartilage grafts obtained from patient’s own cells

  • Stage Product In Development
  • Industry Biotechnology
  • Location Barcelona Wine Bar & Restaurant, Temple Street, New Haven, CT, US
  • Currency EUR
  • Employees 1
  • Website

Company Summary

REGENEAR is a platform to manufacture implants indicated for:
- patients who need reconstructive surgery due to birth defects or trauma, and
- cosmetic surgeries where a cartilage graft is needed to augment or alter the shape of a patient’s ear, nose or chin.
REGENEAR has built an outstanding network of world experts on tissue regeneration, patients target for this technology and renowned specialised surgeons willing to test these implants.


  • Default avatar
    Elazer Edelman
    MD, PhD, FACC

    Thomas D. and Virginia W. Cabot Professor of Health Science and Technology, MIT.
    Professor of Medicine, Harvard Medical School.
    Prof. E. Edelman has pioneered basic findings in the development and assessment of biotechnology. He has helped to create guidelines for the evaluation and clinical approval of biomedical devices and pharmaceutical therapies.

  • Default avatar
    Agata Gelaberto

    IQS. Chemical Engineering.
    Mrs. A. Gelabertó has 13-year long experience in a multinational company (Dannon) leading innovation projects, brand marketing and new business.
    She and her husband Mr. A. Milé are the parents of Andrea – who was born with microtia.

  • Default avatar
    Albert Milé

    IQS. Chemical Engineering.
    Mr. A. Milé has a 15-year-long experience in business, sales and operations management in several national and multinational companies.

  • Default avatar
    Mercedes Balcells

    IQS. Chemical Engineering.
    Ph.D. (Summa cum laude). RWTH Aachen. Chemistry.
    Research Scientist at Harvard-MIT Division of Health Sciences and Technology.
    Full Professor en Institut Quimic de Sarria
    Dr. M. Balcells is an expert in tissue engineering, creating controlled cellular environments that allow understanding cell-cell and cell-material interactions in vitro.

  • Default avatar
    Jose Canseco
    MD/PhD Candidate

    MD/PhD Candidate in the Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, M.I.T.

  • Default avatar
    Charles Vacanti
    Vandam/Covino Professor

    Chairman of the Department of Anesthesia at Brigham & Women's Hospital
    Director, Laboratories for Tissue Engineering and Regenerative Medicine, BWH.
    Dr. Vacanti is one of the most prestigious scientifics in the field of tissue engineering.

  • Default avatar
    Koji Kojima
    M.D., Ph.D.

    Assistant Professor, Harvard Medical School
    Scientific Director, Laboratories for Tissue Engineering and Regenerative Medicine, BWH